Literature DB >> 24076969

Virological, serological, and antiviral studies in an imported human case of avian influenza A(H7N9) virus in Taiwan.

Pi-Han Lin1, Tai-Ling Chao, Shuenn-Wen Kuo, Jann-Tay Wang, Chien-Ching Hung, Huan-Chun Lin, Zong-Yu Yang, Shu-Yuan Ho, Chun-Kai Chang, Ming-Siang Huang, Hui-Hou Chen, Yee-Chun Chen, Hong-Shiee Lai, Sui-Yuan Chang, Shan-Chwen Chang, Pan-Chyr Yang.   

Abstract

We describe the clinical course and virological characteristics of the first H7N9 influenza case in a Taiwanese patient; this patient had detectable viruses in the airway for 2 weeks, during which time an oseltamivir resistance-associated R292K mutation rapidly emerged. Anti-H7N9 antibody was detected 21 days after onset of symptoms, when H7N9 viral load declined significantly.

Entities:  

Keywords:  H7N9; oseltamivir; resistance

Mesh：

Substances：

Year:  2013        PMID： 24076969     DOI： 10.1093/cid/cit638

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  23 in total

1.  The R292K mutation that confers resistance to neuraminidase inhibitors leads to competitive fitness loss of A/Shanghai/1/2013 (H7N9) influenza virus in ferrets.

Authors:  Hui-Ling Yen; Jie Zhou; Ka-Tim Choy; Sin Fun Sia; Ooiean Teng; Iris H Ng; Vicky J Fang; Yunwen Hu; Wei Wang; Benjamin J Cowling; John M Nicholls; Yi Guan; Joseph Sriyal Malik Peiris
Journal:  J Infect Dis       Date:  2014-06-20       Impact factor: 5.226

Review 2.  Pandemic potential of avian influenza A (H7N9) viruses.

Authors:  Tokiko Watanabe; Shinji Watanabe; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Trends Microbiol       Date:  2014-09-25       Impact factor: 17.079

3.  Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.

Authors:  Henju Marjuki; Vasiliy P Mishin; Anton P Chesnokov; Joyce Jones; Juan A De La Cruz; Katrina Sleeman; Daisuke Tamura; Ha T Nguyen; Ho-Sheng Wu; Feng-Yee Chang; Ming-Tsan Liu; Alicia M Fry; Nancy J Cox; Julie M Villanueva; Charles T Davis; Larisa V Gubareva
Journal:  J Infect Dis       Date:  2014-08-14       Impact factor: 5.226

4.  Neuraminidase Mutations Conferring Resistance to Oseltamivir in Influenza A(H7N9) Viruses.

Authors:  Henju Marjuki; Vasiliy P Mishin; Anton P Chesnokov; Juan A De La Cruz; Charles T Davis; Julie M Villanueva; Alicia M Fry; Larisa V Gubareva
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

5.  Seroprevalence to avian influenza A(H7N9) virus among poultry workers and the general population in southern China: a longitudinal study.

Authors:  Xin Wang; Shisong Fang; Xing Lu; Cuiling Xu; Benjamin J Cowling; Xiujuan Tang; Bo Peng; Weihua Wu; Jianfan He; Yijun Tang; Xu Xie; Shujiang Mei; Dongfeng Kong; Renli Zhang; Hanwu Ma; Jinquan Cheng
Journal:  Clin Infect Dis       Date:  2014-05-27       Impact factor: 9.079

6.  Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.

Authors:  Yasushi Itoh; Shintaro Shichinohe; Misako Nakayama; Manabu Igarashi; Akihiro Ishii; Hirohito Ishigaki; Hideaki Ishida; Naoko Kitagawa; Takako Sasamura; Masanori Shiohara; Michiko Doi; Hideaki Tsuchiya; Shinichiro Nakamura; Masatoshi Okamatsu; Yoshihiro Sakoda; Hiroshi Kida; Kazumasa Ogasawara
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

7.  Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.

Authors:  Peter Pushko; Lindsey M Pujanauski; Xiangjie Sun; Melissa Pearce; Rachmat Hidajat; Thomas Kort; Louis M Schwartzman; Irina Tretyakova; Liu Chunqing; Jeffery K Taubenberger; Terrence M Tumpey
Journal:  Vaccine       Date:  2015-07-21       Impact factor: 3.641

8.  Human H7N9 and H5N1 influenza viruses differ in induction of cytokines and tissue tropism.

Authors:  Victoria A Meliopoulos; Erik A Karlsson; Lisa Kercher; Troy Cline; Pamela Freiden; Susu Duan; Peter Vogel; Richard J Webby; Yi Guan; Malik Peiris; Paul G Thomas; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

9.  Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus.

Authors:  Xiaohui Li; Peter Pushko; Irina Tretyakova
Journal:  J Vaccines Vaccin       Date:  2015-06-30

10.  Genomic Signatures for Avian H7N9 Viruses Adapting to Humans.

Authors:  Guang-Wu Chen; Shu-Ming Kuo; Shu-Li Yang; Yu-Nong Gong; Mei-Ren Hsiao; Yi-Chun Liu; Shin-Ru Shih; Kuo-Chien Tsao
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.